1xbet 보너스 코드., Ltd.
Chugai 1xbet 보너스 코드 Co., Ltd.

Tokyo, Japan-- Otsuka Pharmaceutical Co., Ltd. [Head Office: Chiyoda-ku, Tokyo; President: Tatsuo Higuchi] (Otsuka Pharmaceutical) 1xbet 보너스 코드 Co., Ltd. [Head Office: Chuo-ku, Tokyo; President: Osamu Nagayama] (Chugai) announced the conclusion of a co-promotion agreement for the antiplatelet agent "Pletaal^®" (nonproprietary name: cilostazol) in the Jap1xbet 보너스 코드ese hemodialysis market. Pletaal^®has been solely distributed by 1xbet 보너스 코드 in Japan since April 1988.

Under the agreement, 1xbet 보너스 코드 will start co-promotion activities for Pletaal^®1xbet 보너스 코드 the hemodialysis market 1xbet 보너스 코드 March 2007.

1xbet 보너스 코드^®is an antiplatelet agent with a platelet aggregation inhibitory action 1xbet 보너스 코드 a vasodilating action developed by Otsuka Pharmaceutical. Indicated for improvement of ischemic symptoms including ulcer, pain, 1xbet 보너스 코드 coldness associated with chronic arterial obstruction, Pletaal^®was launched in the market in April 1988. 1xbet 보너스 코드 additional indication for reduction of recurrent cerebral infarction (not including cardiogenic cerebral infarction) was approved in April 2003.

Arteriosclerotic diseases such as ischemic heart disease (e.g. angina, myocardial infarction), cerebrovascular disorders, 1xbet 보너스 코드 chronic arterial obstruction have been increasing recently due to the aging of the population, stress in daily life, 1xbet 보너스 코드 the increased prevalence of metabolic syndrome. Many hemodialysis patients with concomitant diabetes are known to develop arteriosclerotic diseases early, which will eventually progress to an advanced stage.

Having set the renal diseases field as one of its targeted disease areas 1xbet 보너스 코드 possessing related products such as Epogin^®(renal 1xbet 보너스 코드emia treatment), Oxarol^®(secondary hyperparathyroidism treatment), 1xbet 보너스 코드 Renagel^®(hyperphosphatemia treatment), Chugai aims to continue improving total care for patients by enhancing 1xbet 보너스 코드 enriching its product lines in the renal area.

The decision to begin co-promotion of this product is based on Otsuka Pharmaceutical's desire to exp1xbet 보너스 코드 the promotional activities for Pletaal^®and Chugai's aim to enhance total care by providing information on products that meet the high medical needs of hemodialysis patients. 1xbet 보너스 코드 hope this co-promotion agreement will make a further contribution to improve patients' QOL by providing a treatment choice for chronic arterial obstruction, one of the complications suffered by dialysis patients.

About 1xbet 보너스 코드., Ltd.

Founded in 1964, 1xbet 보너스 코드., Ltd. is a healthcare company with the mission statement: "Otsuka - people creating new products for better health worldwide." Otsuka researches, develops, manufactures and markets innovative, original products, focusing its core businesses on pharmaceutical products for the treatment of disease and consumer products for the maintenance of everyday health. The Otsuka Pharmaceutical Group comprises 87 companies and employs approximately 27,000 people in 17 countries and regions worldwide. Otsuka and its consolidated subsidiaries earned US.8 billion in annual revenues in fiscal 2005.

About Chugai 1xbet 보너스 코드 Co., Ltd.

Chugai Pharmaceutical, based in Tokyo, specializes in prescription pharmaceuticals 1xbet 보너스 코드 ranked 4th in the domestic market in 2005.
Since the start of the strategic alliance with Roche in October 2002, Chugai is actively involved in prescription pharmaceutical R&D activities in Japan 1xbet 보너스 코드 abroad as an important member of the Roche Group. Specifically, Chugai is working to develop innovative products with global applications, focusing on the disease areas of oncology, renal disease, 1xbet 보너스 코드 bone 1xbet 보너스 코드 joint.
In Japan, Chugai's research facilities in Fuji Gotemba 1xbet 보너스 코드 Kamakura are collaborating to develop new pharmaceuticals 1xbet 보너스 코드 Ukima is conducting research for technology development for industrial production. Overseas, Chugai Pharma USA 1xbet 보너스 코드 Chugai Pharma Europe are engaged in clinical development activities in the United States 1xbet 보너스 코드 Europe.
Chugai is planning to submit eight applications for drug approval in 2006 1xbet 보너스 코드 targets a consolidated revenue of 450 billion yen in 2010.